In patients hospitalized with COVID-19, adding azithromycin to usual care did not reduce 28-d mortality.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 34058103.
- Also identified by DOI 10.7326/ACPJ202106150-064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
RECOVERY Collaborative Group. <b>Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.</b> Lancet. 2021;397:605-12. 33545096.
Medical subject headings
- Azithromycin
- COVID-19 Drug Treatment